Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

129.45 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
49 50 Next >
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices. 
Via Benzinga
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit
The company expects to earn an adjusted $5.05 to $5.25 per share this year, in line with forecasts for $5.16. 
Via Investor's Business Daily
US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday. 
Via Benzinga
Topics Artificial Intelligence Government
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks. 
Via Benzinga
Topics Government Stocks
How Is The Market Feeling About Abbott Laboratories?
 
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
 
Via Benzinga
ABBOTT LABORATORIES (NYSE:ABT) Technical Analysis observations.
Will ABBOTT LABORATORIES breakout? 
Via Chartmill
Earnings Scheduled For January 22, 2025
 
Via Benzinga
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
 
Via Benzinga
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
Via The Motley Fool
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
The U.S. Food and Drug Administration announced a ban on Red No. 3, an artificial food coloring linked to cancer in animal studies, effective Jan. 15, 2027. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees
Via The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030. 
Via Benzinga
2 No-Brainer Dividend Stocks to Buy With $250 in 2025
Via The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Via The Motley Fool
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years
Via The Motley Fool
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Via The Motley Fool
10 Dividend Stocks For Intergenerational Wealth
The Dividend Aristocrats broadly have durable competitive advantages, and long-term growth. 
Via Talk Markets
Topics Stocks / Equities
Introducing the "Dividend Seven" Stocks
Via The Motley Fool
My Top 10 Stocks to Buy for 2025
Via The Motley Fool
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
Via The Motley Fool
The Smartest Dividend Stocks to Buy With $500 Right Now
Via The Motley Fool
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation. 
Via Benzinga
“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”
Via AB Newswire
2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Via The Motley Fool
ABBOTT LABORATORIES (NYSE:ABT) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Exploring ABBOTT LABORATORIES's Technical Signals and Breakout Potential. 
Via Chartmill
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.